Free tool
FAERS Monitor: Tenormin
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018240 or its brand name (Tenormin, Atenolol). Reports on generic versions are filed under their own applications.
Reports
133,241
Serious
93,431
70% of reports
Hospitalization
48,042
Death reported
11,331
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective8,061
- nausea7,924
- fatigue7,694
- diarrhoea7,124
- dyspnoea6,387
- dizziness6,333
- headache5,989
- pain5,767
- asthenia5,012
- fall4,728
- arthralgia4,669
- malaise4,305
- vomiting4,232
- hypertension4,111
- off label use4,092
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 4,208 |
| 2005 | 4,818 |
| 2006 | 4,685 |
| 2007 | 4,035 |
| 2008 | 4,456 |
| 2009 | 5,158 |
| 2010 | 6,629 |
| 2011 | 6,664 |
| 2012 | 7,429 |
| 2013 | 6,456 |
| 2014 | 8,239 |
| 2015 | 9,678 |
| 2016 | 9,111 |
| 2017 | 8,094 |
| 2018 | 8,469 |
| 2019 | 7,496 |
| 2020 | 6,223 |
| 2021 | 4,826 |
| 2022 | 4,230 |
| 2023 | 3,598 |
| 2024 | 3,327 |
| 2025 | 3,211 |
| 2026 | 2,195 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,920,918 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| hypertensionSignal | 4,111 | 3.1 | 3.0 | 5,809 |
| fallSignal | 4,728 | 2.3 | 2.2 | 3,327 |
| astheniaSignal | 5,012 | 2.1 | 2.1 | 2,975 |
| dizzinessSignal | 6,333 | 2.0 | 2.0 | 3,284 |
| dyspnoea | 6,387 | 1.8 | 1.7 | 2,262 |
| arthralgia | 4,669 | 1.8 | 1.7 | 1,613 |
| diarrhoea | 7,124 | 1.8 | 1.7 | 2,338 |
| nausea | 7,924 | 1.6 | 1.6 | 1,766 |
| fatigue | 7,694 | 1.6 | 1.5 | 1,616 |
| malaise | 4,305 | 1.6 | 1.5 | 862 |
| headache | 5,989 | 1.5 | 1.5 | 1,062 |
| pain | 5,767 | 1.5 | 1.4 | 937 |
| vomiting | 4,232 | 1.4 | 1.4 | 543 |
| drug ineffective | 8,061 | 1.0 | 0.9 | 11 |
| off label use | 4,092 | 0.7 | 0.7 | 401 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.